Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HOX transcript antisense RNA (HOTAIR) is a 2,148-nucleotide long human long non-coding RNA (lncRNA) transcribed from the HOXC locus on chromosome 12[3]. It is best known for its role in regulating chromatin structure and gene expression via trans-acting epigenetic silencing: HOTAIR binds Polycomb Repressive Complex 2 (PRC2) through its 5'-domain and LSD1/CoREST/REST through its 3'-domain, enabling it to guide these complexes to the HOXD locus (chromosome 2) and repress gene transcription[1][3]. HOTAIR is implicated in physiological processes such as epidermal and bone development, as well as in the pathogenesis of many cancers, where its high expression correlates with metastasis, poor prognosis, and increased invasiveness. It can also act as a competing endogenous RNA (ceRNA) in cytoplasm, binding miRNAs such as miR-214 to modulate differentiation[2]. As a lncRNA, HOTAIR does not encode a protein and is distinguished by its stable, modular secondary structure essential for interactions with chromatin-modifying enzymes and regulatory proteins[1][4]. No drugs currently target HOTAIR directly in clinical practice, but it is viewed as a promising therapeutic target and biomarker in oncology and bone metabolism due to its critical role in epigenetic gene regulation[5].
Inhibition of HOTAIR function (via antisense oligonucleotides or RNA interference) aims to block epigenetic gene silencing and tumor progression; experimental approaches seek to disrupt HOTAIR–PRC2 or HOTAIR–LSD1 interactions[1][4][5]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HOX transcript antisense RNA (HOTAIR).